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While priming is most often thought of as a strategy for modulating neural excitability 
to facilitate voluntary motor control, priming stimulation can also be utilized to target 
spinal reflex excitability. In this application, priming can be used to modulate the invol-
untary motor output that often follows central nervous system injury. Individuals with 
spinal cord injury (SCI) often experience spasticity, for which antispasmodic medica-
tions are the most common treatment. Physical therapeutic/electroceutic interventions 
offer an alternative treatment for spasticity, without the deleterious side effects that 
can accompany pharmacological interventions. While studies of physical therapeutic/
electroceutic interventions have been published, a systematic comparison of these 
approaches has not been performed. The purpose of this study was to compare four 
non- pharmacological interventions to a sham-control intervention to assess their efficacy 
for spasticity reduction. Participants were individuals (n = 10) with chronic SCI (≥1 year) 
who exhibited stretch-induced quadriceps spasticity. Spasticity was quantified using the 
pendulum test before and at two time points after (immediate, 45 min delayed) each 
of four different physical therapeutic/electroceutic interventions, plus a sham-control 
intervention. Interventions included stretching, cyclic passive movement (CPM), trans-
cutaneous spinal cord stimulation (tcSCS), and transcranial direct current stimulation 
(tDCS). The sham-control intervention consisted of a brief ramp-up and ramp-down of 
knee and ankle stimulation while reclined with legs extended. The order of interventions 
was randomized, and each was tested on a separate day with at least 48 h between 
sessions. Compared to the sham-control intervention, stretching, CPM, and tcSCS were 
associated with a significantly greater reduction in spasticity immediately after treatment. 
While the immediate effect was largest for stretching, the reduction persisted for 45 min 
only for the CPM and tcSCS interventions. tDCS had no immediate or delayed effects on 
spasticity when compared to sham-control. Interestingly, the sham-control intervention 
was associated with significant within-session increases in spasticity, indicating that 
spasticity increases with immobility. These findings suggest that stretching, CPM, and 
tcSCS are viable non-pharmacological alternatives for reducing spasticity, and that 
CPM and tcSCS have prolonged effects. Given that the observed effects were from a 
single-session intervention, future studies should determine the most efficacious dosing 
and timing strategies.
Keywords: spasticity, spinal cord injury, stretching, cyclic passive movement, transcutaneous spinal cord 
stimulation, tanscranial direct current stimulation
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inTrODUcTiOn
In recent years, priming via physical therapeutic and/or 
electroceutic techniques has been used for modulating neural 
excitability and improving motor learning (1). While priming 
is most typically regarded as a strategy to facilitate voluntary 
motor control in the context of rehabilitation, the use of priming 
stimulation for the modulation of involuntary motor activity 
following central nervous system (CNS) injury has received less 
attention. Priming could likewise be used to target the spinal 
circuitry, thus modulating the excitability of the spinal reflexes. 
This type of priming stimulation could be a useful tool for the 
modulation of aberrant involuntary motor output following CNS 
injury.
Following spinal cord injury (SCI), disruption in communica-
tion between the brain and spinal cord causes an imbalance in 
the modulatory inputs to spinal reflex circuitry. The consequence 
of which includes spastic hypertonia and increased reflex excit-
ability, commonly referred to as spasticity, that can impair motor 
function and diminish quality of life. Antispasmodic medication 
is the standard treatment for spasticity. While pharmacological 
treatments can effectively decrease hyperexcitability in the spinal 
circuitry and normalize exaggerated muscle tone [for review, 
see Ref. (2)], they are costly and are associated with a number of 
deleterious side effects, including weakness, lethargy, and drowsi-
ness (3–5), which may limit functional improvements.
Physical therapeutic/electroceutic interventions are non-
pharmacological approaches that utilize mechanical and 
electrical stimulation to modulate the state of excitability of 
the nervous system (2, 6–10). Importantly, these interventions 
are often inexpensive and not associated with the negative side 
effects commonly observed with antispasmodic medications. 
In the context of spasticity, physical therapeutic/electroceutic 
interventions can modulate spinal cord inputs and rebalance 
modulatory influences on the spinal circuitry. Therefore, the 
priming stimulation provided by these interventions has the 
potential to modulate involuntary motor output and thereby 
reduce spasticity.
Stretching is a commonly used physical therapeutic interven-
tion for the management of spasticity (11) that provides constant 
afferent activation throughout the duration of the stretch. 
Although the mechanisms by which stretching modulates the 
spinal reflex circuitry are not well characterized, stretching has 
been shown to improve clinical measures of spasticity (12) and 
decrease ankle resistance torque (13) in individuals with spastic-
ity. In contrast to the continuous afferent activation provided 
during stretching, cyclic passive movement (CPM) primes the 
spinal circuitry by supplying repeated, patterned afferent input 
to the spinal cord. The activation of afferent fibers that occurs 
during movement is thought to play a critical role in spinal reflex 
modulation, as experimental evidence shows that prolonged joint 
immobilization causes reflex hyperexcitability in non-injured 
individuals (14). Moreover, CPM has been shown to improve 
Modified Ashworth scores (a clinical measure of spasticity) and 
restore post-activation depression in persons with SCI (8, 15).
While stretching and CPM activate discrete sets of afferent 
inputs with a temporal pattern that can be varied, transcutaneous 
spinal cord stimulation (tcSCS) continuously stimulates spinal 
afferents at multiple segmental levels concurrently. Early work 
with spinal cord stimulation used implanted epidural electrodes 
to reduce spasticity in persons with multiple sclerosis (16, 17), 
stroke (18), and SCI (19, 20). More recently, epidural stimula-
tion of the lumbar spinal cord at a frequency ranging from 50 to 
100 Hz has been shown to reduce lower extremity spasticity (21). 
Stimulation over the spinal cord using tcSCS at 50 Hz has also 
been shown to reduce lower extremity spasticity in a case series of 
persons with chronic, incomplete SCI (9). While epidural lumbar 
spinal cord stimulation and tcSCS both stimulate large diameter 
dorsal root fibers for the modulation of spinal reflex circuitry (6, 
22), tcSCS is a non-invasive method for stimulating the spinal 
cord circuitry making it a more clinically accessible electroceutic 
intervention for reducing spasticity.
Because supraspinal inputs contribute to the modulation of 
spinal reflex excitability, priming stimulation targeting the cortex 
can be utilized to enhance descending drive to inhibitory circuits 
in the spinal cord and thus modulate the excitability of the spinal 
reflex circuitry. Supraspinal circuits have been shown to activate 
inhibitory mechanisms in the spinal circuitry (23–26). Therefore, 
non-invasive brain stimulation (NIBS) techniques can be used 
to target inhibitory spinal circuitry indirectly by increasing the 
excitability of supraspinal inputs that activate inhibitory spinal 
circuits. Transcranial direct current stimulation (tDCS) is a form 
of NIBS that has been shown to increase corticospinal excitability 
in persons with SCI (27). A recent study demonstrated that excita-
tory stimulation of the motor cortex with anodal tDCS reduces 
spasticity in individuals with cerebral palsy (28). To the best of 
our knowledge, tDCS has not been evaluated as a treatment for 
spasticity in persons with SCI. However, another form of NIBS, 
repetitive transcranial magnetic stimulation, has been shown to 
decrease spasticity in individuals with SCI (10, 29), suggesting 
that tDCS could potentially improve spasticity post-SCI as well.
While numerous physical therapeutic/electroceutic interven-
tions have been investigated as treatments for spasticity, a sys-
tematic comparison of multiple therapies in the same individuals 
has not been performed. Consequently, the purpose of this 
study was to compare stretching, CPM, tcSCS, and tDCS with a 
sham-control to determine their efficacy as physical therapeutic/
electroceutic interventions for the reduction of lower extremity 
spasticity in persons with chronic SCI (>1 year post-injury). Our 
goal was to determine whether one of these physical therapeutic/
electroceutic interventions emerged as a more efficacious therapy 
for the management of spasticity that could then serve as the basis 
for continued research.
MaTerials anD MeThODs
This study was carried out with approval of the Shepherd Center 
Research Review Committee. All the participants gave written 
informed consent prior to study enrollment in accordance with 
the Declaration of Helsinki.
subjects
Individuals were eligible to participate if they met the following 
inclusion criteria: 18–65 years of age with a chronic SCI (≥1 year 
TaBle 1 | Participant demographics.
Participant gender age (years) Time since injury ais neurological injury level le tested antispastic agents
1 M 29 2 years, 5 months B C6 R Baclofen
2 M 41 6 years, 8 months C T6 L Baclofen
3 M 57 2 years, 9 months D C5 L Baclofen
4 M 45 12 years, 1 month B T10 L None
5 M 49 9 years, 2 months D C4 R Baclofen
6 M 60 2 years, 0 months D C4 R None
7 F 36 2 years, 5 months D C6 R None
8 M 24 4 years, 0 months C T7 L Baclofen
9 M 61 2 years, 8 months D C4 L Baclofen
10 F 60 10 years, 10 months B T12 L None
AIS, American Spinal Injury Association Impairment Scale; LE, lower extremity.
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post-injury), any International Standards for Neurological 
Classification of SCI (ISNCSCI) classification level, and self-
reported spasticity in the lower extremities. Individuals with the 
following exclusion criteria were excluded from participation: 
neurological level of injury below T12, orthopedic problems 
that would prevent participation in study interventions (i.e., 
contracture or heterotopic ossification that limited knee or hip 
range of motion >10°), implanted stimulators of any type, or 
active infection. Individuals taking prescription medications for 
management of spasticity were eligible for participation in the 
study provided that the dosage was stable (no change <2 weeks 
prior to enrollment).
Of the 18 participants recruited for this study, 10 subjects 
completed the study with one subject declining to participate 
in the tDCS session. Participant demographics can be found in 
Table 1. All participants had SCI of traumatic origin.
interventions
We used a randomized crossover design consisting of a single 
session each of four different physical therapeutic/electroceutic 
interventions and a sham-control intervention. Sessions were 
separated by a minimum of 48  h to prevent carryover effects 
between stimulation types.
Stretching
Study physical therapists performed a series of stretches targeting 
the hip flexors/extensors, knee flexors/extensors, and ankle plan-
tarflexors. Participants were positioned in supine for stretching of 
the hip extensors, knee flexors, knee extensors, and ankle plan-
tarflexors and repositioned in sidelying with the pelvis in neutral 
alignment for stretching of the hip flexors. Each stretch position 
was held for a total of 60 s. Muscles in both lower extremities (i.e., 
the test and non-test leg) were stretched three times each.
Cyclic Passive Movement
A treadmill-mounted robotic gait orthosis (Lokomat, Hocoma 
Inc., Norwell, MA, USA) was used for CPM of the lower 
extremities. Participants were secured into the robotic gait 
orthosis using a body-weight support harness and instructed 
to remain relaxed and allow the device to move their legs for 
30 min. CPM parameters varied among participants. The lowest 
amount of body-weight support and quickest step speed that 
an individual could tolerate while maintaining normal gait 
kinematics (i.e., adequate toe clearance during the swing phase) 
were utilized.
Transcutaneous Spinal Cord Stimulation
Electrical stimulation was applied over vertebral levels T11/T12 
using a portable electrotherapy unit (Empi Continuum, DJO 
Global, Vista, CA, USA). A small round electrode (5  cm) was 
placed on the back in the area between T11–T12, and one but-
terfly electrode (10 cm × 15 cm) was placed over the umbilicus 
in a montage analogous to a previous study investigating the use 
of tcSCS as a treatment for spasticity (9). Biphasic, 50 Hz stimula-
tion intensity was slowly increased until paresthesia of the lower 
legs and feet was achieved (for those individuals with sensation 
below the level of injury) or to the highest level the subject could 
tolerate without discomfort (for those individuals without sensa-
tion below the level of injury). Additionally, target stimulation 
intensity was subthreshold for lower extremity muscle activation 
as verified by the absence of visible twitches in lower extremity 
muscles. Once this target stimulation intensity was reached, 
stimulation was delivered for 30 min similar to previous work (9).
Transcranial Direct Current Stimulation
Non-invasive brain stimulation was delivered using a constant 
current stimulator (1 × 1 tDCS device, Soterix Medical Inc., New 
York, NY, USA). Stimulation was applied for 20 min at an inten-
sity of 2 mA as a recent study suggested that this is the necessary 
stimulation intensity for modulating corticospinal excitability in 
persons with SCI (27). Using the 10–20 electroencephalographic 
system, the anode (35 cm2) was placed 1 cm anterior to the vertex 
(Cz), and the cathode (35 cm2) was placed over the inion. This 
electrode montage has been shown to increase corticospinal 
excitability to both lower extremities concurrently (30).
Sham-Control Stimulation
The sham-control condition was designed to detect any non-
intervention related study effects (i.e., resting in semi-reclined 
position with legs elevated, placebo effects). Subjects were seated 
in a semi-reclined position on a padded, adjustable height mat 
table with their lower legs extended and resting on a chair. This 
position was selected as subjects were also seated in the same 
manner for the other interventions that did not involve movement 
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FigUre 1 | Quantifying spasticity using the pendulum test. (a) 
Schematic of pendulum test experimental setup. (B) Representative knee 
angle response profile of an individual with spasticity during the pendulum 
test. The first swing excursion is defined as the angle at which the lower leg 
transitions from flexion to extension during after the heel of the test leg is 
released.
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(i.e., tcSCS and tDCS). Electrodes were placed over the medial 
and lateral malleoli and the medial and lateral tibial plateaus. 
Stimulation intensity was increased until the subject could feel 
the stimulation (for those individuals with sensation below the 
level of injury). After the sensory threshold was reached, the 
subjects were told that the stimulation would be decreased to a 
subthreshold level when, in fact, the stimulation was turned off. 
Although the stimulation was off for the 30-min session, it was 
important to deliver a brief period of stimulation at the beginning 
of the session to provide an input that the subjects could perceive 
as treatment. To limit the potential effect of movement-related 
afferent input, subjects remained seated with legs extended for 
30 min after the stimulation was stopped.
assessment of spasticity
The lower extremity with greater spasticity, as determined by sub-
ject self-report, was identified upon study enrollment. All assess-
ments were conducted in the same lower extremity throughout 
the duration of the study. For each session, assessments were 
completed at three time points: (1) prior to the start of the inter-
vention (baseline), (2) immediately after the conclusion of the 
intervention (immediate), and (3) 45 min after the conclusion of 
the intervention (delayed). To account for intra-individual differ-
ences in spasticity between sessions, the immediate and delayed 
effects for each intervention were compared to the baseline values 
obtained immediately prior to the intervention.
The pendulum test, a biomechanical measure of stretch-
induced quadriceps spasticity, which has been shown to correlate 
with clinical measures of spasticity in persons with SCI (31), was 
selected as the spasticity measure for this study (see Figure 1A for 
diagram of experimental setup). Three pendulum test trials were 
completed at each of the three assessment time points (baseline, 
immediate, delayed); each trial was separated by a minimum of 
30  s. An electrogoniometer (model # SG150, Biometrics Ltd., 
Newport, UK) strapped to the lateral aspect of the knee joint 
with neoprene wraps was used to measure joint kinematics, and 
an electromyographic (EMG) recording electrode (Motion Lab 
Systems, Baton Rogue, LA, USA) placed over the rectus femoris 
was used to confirm stretch-induced quadriceps activation dur-
ing the pendulum test. Spike software (Cambridge Electronic 
Design Limited, Cambridge, England) was used for acquisition 
and analysis of joint angle and quadricep EMG data.
The pendulum test was performed as previously described 
(32). Briefly, the subject was seated on a padded, adjustable height 
mat table in a semi-reclined position with their lower legs hanging 
over the edge of the mat. The examiner grasped the participant’s 
heel and fully extended the test leg. The examiner then released 
the heel allowing the lower leg to swing. This gravity-induced 
movement of the lower leg stretches the quadriceps muscle and 
elicits a stretch reflex-induced contraction of the quadriceps, 
which is reflected in the knee angle.
The primary outcome measure for this pilot study was the first 
swing excursion (FSE) of the knee joint during the pendulum test 
(see Figure 1B for an illustration of the FSE during a representa-
tive knee angle response profile). Previous research suggests that 
FSE is a better indicator of spasticity than other pendulum test 
components such as the number of oscillations or relaxation 
index (33). FSE is the angle at which the movement of the lower 
leg reverses from flexion to extension after release of the heel. 
This measurement represents the point during gravity-induced 
knee flexion at which the stretch-induced spasticity of the quadri-
ceps triggers a reflex contraction. An increased FSE represents 
a decrease in spasticity as the quadriceps stretches to a longer 
length before a reflex contraction is elicited. For each assessment, 
the mean of three FSEs was calculated for each participant.
Data analysis
SPSS version 22 (IBM, Armonk, NY, USA) was used for all statisti-
cal analyses. Data are presented as the mean ± SEM. Significance 
was set at α = 0.05 for all analyses. Differences between each of 
the five different interventions were evaluated using repeated 
measures one-way ANOVA with post hoc Bonferroni correction 
for multiple comparisons. The within-session effects of each 
intervention were evaluated using Paired Student’s t-tests. The 
effect size of each intervention was calculated using Cohen’s d.
resUlTs
Treatment effects compared to  
sham-control intervention
Immediate Effects
To determine the immediate effect of each physical therapeutic/
electroceutic intervention on spasticity, we first calculated the 
change in FSE from baseline to immediately posttreatment for 
each intervention (Figure 2A). When comparing changes in FSE 
TaBle 2 | comparison of change in first swing excursion (Fse) between 
each physical therapeutic/electroceutic intervention and sham-control.
change in Fse from 
baseline compared to 
sham-control
immediate Delayed
Stretching (n = 10) 17.36* (1.62) 15.28 (1.25)
Cyclic passive movement (n = 10) 16.87* (1.27) 17.74* (1.23)
Transcutaneous spinal cord stimulation (n = 10) 15.15* (1.31) 17.53* (1.49)
Transcranial direct current stimulation (n = 9) 8.81 (0.70) 10.72 (0.93)
Effect size for change in FSE listed in parentheses. Results represent the difference 
of the mean change in FSE from baseline between each physical therapeutic/
electroceutic intervention and the sham-control.
*p < 0.05.
FigUre 2 | change in group mean first swing excursion (Fse) values 
from baseline to immediate post-test (a) and delayed post-test 
(B). Results represent means ± SEM. *p < 0.05; **p < 0.01.
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for each intervention to the sham-control intervention at the 
immediate post-test, we found that a single session of stretching, 
CPM and tcSCS was associated with a significant mean change 
in FSE compared to sham-control (Table  2; one-way ANOVA, 
Bonferroni post hoc test, p < 0.05). These changes met the criteria 
for large effect sizes (34) at 1.62 (stretching), 1.27 (CPM), and 1.31 
(tcSCS). A single session of tDCS did not result in a significant 
change in FSE compared to sham-control (Table  2; one-way 
ANOVA, Bonferroni post hoc test, p = 0.826).
Delayed Effects
To determine the delayed effect of each physical therapeutic/
electroceutic intervention on spasticity, we calculated the change 
in FSE from baseline to 45 min posttreatment (delayed) for each 
intervention (Figure 2B). In comparing changes in FSE for each 
intervention to the sham-control intervention at the delayed 
post-test, we found that only CPM and tcSCS had significant 
increases in mean FSE compared to sham-control (Table  2; 
one-way ANOVA, p < 0.05) with effect sizes of 1.23 (CPM) and 
1.49 (tcSCS). While stretching showed immediate changes in 
FSE, these effects appeared to be short term, as the change in 
FSE showed no significant difference compared to sham-control 
45 min after treatment (Table 2; one-way ANOVA, Bonferroni 
post hoc test, p = 0.052). It should be noted, however, that stretch-
ing had an effect size of 1.25, indicating a large effect. tDCS was 
found to have no significant delayed effect on the FSE compared 
to sham-control (Table 2; one-way ANOVA, Bonferroni post hoc 
test, p = 0.510).
There was no significant difference in FSE when comparing 
each physical therapeutic/electroceutic intervention to each other 
at either the immediate or delayed post-test (one-way ANOVA, 
Bonferroni post hoc test, p > 0.10), indicating that no one physical 
therapeutic/electroceutic treatment provided greater reduction 
in spasticity than another.
Treatment effects within intervention
In comparing changes in FSE within each intervention, we found 
that the mean FSE decreased following the 30-min sham-control 
intervention (Table  3; Figure  3A), indicating an increase in 
spasticity. While a majority of subjects showed a decrease in FSE 
after sham-control treatment, two subjects had an increase in FSE 
suggestive of a placebo effect of the sham-control intervention for 
these individuals. Further analysis of the within-session effects of 
the sham-control intervention showed that there was a significant 
decrease in the mean FSE from baseline to 45 min after treatment 
(paired-t-test, t = 2.718, p = 0.024) with a moderate effect size 
of 0.65. Taken together, these findings indicate that inactivity, as 
occurred in the sham-control, may worsen spasticity.
Within-treatment assessments of each physical therapeutic/
electroceutic intervention showed that the effects of each treat-
ment varied across subjects (Figure 3). Analysis of the within-
treatment effects of a single stretching session showed that the 
FSE increased in 9/10 subjects (Figure 3B). Of those responders, 
two showed an increase in FSE of 12 ° or greater, which has been 
identified as a clinically meaningful difference in FSE as observed 
in a study of the antispasmodic tizanidine (31). Six subjects 
showed a moderate increase in FSE of 6–11°, and one showed 
a mild increase in FSE of 1–5°. On average, stretching resulted 
in a statistically significant increase in FSE from baseline to 
immediately after stretching (Table 3; paired-t-test, t = −4.354, 
p = 0.002) with a moderate effect size. There was no significant 
difference in FSE at the delayed post-test (Table 3; paired t-test, 
t = −1.005, p = 0.341), indicating the effects were short term.
FigUre 3 | Within-session first swing excursion (Fse) values for each intervention: (a) sham-control, (B) stretching, (c) cyclic passive movement 
(cPM), (D) transcutaneous spinal cord stimulation (tcscs), and (e) transcranial direct current stimulation (tDcs). In each panel, the thin, colored lines 
display individual results for each participant and the bold black line displays the mean for all participants. One participant declined to participate in tDCS; hence, 
there are only nine participants displayed for this intervention. Individual results represent means of three pendulum tests and group means represent the mean of all 
individual trials. Abbreviations: Pre, baseline; PostIm, immediate post-test; PostD, delayed post-test. *p < 0.05; **p < 0.01.
TaBle 3 | group mean first swing excursion (Fse) values for each intervention.
Fse
Baseline immediate Delayed
Stretching (n = 10) 49.62 ± 4.26 57.80 ± 3.89** (0.63) 52.83 ± 4.34 (0.24)
Cyclic passive movement (n = 10) 49.63 ± 6.23 57.32 ± 5.34 (0.42) 55.29 ± 5.19 (0.31)
Transcutaneous spinal cord stimulation (n = 10) 47.70 ± 4.64 53.67 ± 5.29 (0.38) 53.16 ± 5.12 (0.35)
Transcranial direct current stimulation (n = 9) 50.70 ± 6.12 50.33 ± 5.46 (0.02) 49.34 ± 5.04 (0.08)
Sham-control (n = 10) 56.88 ± 5.99 47.70 ± 6.55 (0.46) 44.80 ± 5.75* (0.65)
Effect size for within-session pre- and post-test comparisons listed in parentheses. Results represent means ± SEM. *p < 0.05, **p < 0.01.
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Analysis of a single 30-min CPM session showed that the 
mean FSE increased in 8/10 subjects (Figure 3C). Of those eight 
responders, five showed a clinically meaningful increase in FSE 
of 12° or greater and three showed a moderate increase in FSE 
of 6–11°. Even though a number of subjects showed individual 
increases in their FSE after CPM for either the immediate or 
7Estes et al. Priming Reflex Excitability
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While the specific neurophysiological mechanisms underly-
ing spasticity are disputed, it is generally accepted that spasticity 
arises from an imbalance in the excitatory and inhibitory 
inputs into the spinal cord circuitry and that modifying the 
activity of these inputs can rebalance the circuit (2). Of the 
interventions tested in the current study, only those that 
involved the activation of sensory afferents (stretching, CPM, 
and tcSCS) reduced spasticity. Others have also shown afferent 
stimulation via stretching (12), CPM (8, 15), and tcSCS (9) 
decreases spasticity. Given evidence that electrical stimulation 
of sensory afferents remodels the excitability of the spinal reflex 
circuitry by both direct (spinal level) and indirect (cortical 
level) mechanisms (19, 21, 35), it may be possible that the direct 
modulation of sensory afferents results in larger changes in 
FSE than approaches that act via indirect afferent modulation, 
such as tDCS (36).
Interestingly, the value of afferent stimulation does not appear 
to be dependent on the type of afferent input used. Even though 
each intervention activates different populations of sensory 
afferents in a different fashion (i.e., stretching continually 
activates muscle afferents, CPM continually activates muscle 
afferents in a pattern, and tcSCS repeatedly activates afferents 
across multiple spinal segments), we observed no significant 
differences in the change of FSE between stretching, CPM, or 
tcSCS, indicating that these interventions have similar efficacy 
as primers of spinal cord excitability. The value of these physical 
therapeutic/electroceutic interventions may, therefore, lie in 
their individual accessibility, cost, and duration. For most per-
sons with spasticity, stretching is likely to be the most accessible 
and low cost option. However, our finding that stretching only 
significantly increased FSE immediately following treatment 
indicates that the duration of these effects are limited, which may 
be a limitation for spasticity management if continual stretching 
is required. With an increase in FSE persisting for 45 min post-
treatment, CPM provides a more long-term reduction in spastic-
ity than stretching. However, CPM requires costly equipment 
and is not readily portable. The increase in FSE induced by tcSCS 
also persisted for 45 min posttreatment, indicating the potential 
for more long-term treatment effects. Further, the electrotherapy 
units used to deliver tcSCS are both more affordable and more 
portable than CPM devices making them more accessible. This 
rationale suggests that tcSCS may be the most valuable form of 
afferent stimulation for the reduction of stretch-induced spastic-
ity, as measured solely by a change in FSE.
Using priming stimulation to target the supraspinal circuitry 
directly, we did not observe a significant change in FSE when 
comparing tDCS to sham-control. As highlighted above, affer-
ent stimulation provides dual activation of the spinal circuitry, 
both direct and indirect, whereas tDCS theoretically activates 
inhibitory pathways in spinal reflex circuitry indirectly. While 
our results suggest that solely targeting supraspinal inputs is 
less effective than afferent stimulation for reducing stretch-
induced quadriceps spasticity, NIBS should not be ruled out 
as a potential physical therapeutic/electroceutic intervention for 
spasticity management. Other studies investigating the use of 
NIBS for spasticity reduction have utilized a minimum of five 
stimulation sessions (10, 28, 29), indicating that higher doses of 
delayed post-tests, there was no significant mean increase in FSE 
from baseline at the immediate (Table 3; paired t-test, t = −1.932, 
p = 0.085) or delayed post-tests (Table 3; paired t-test, t = −1.202, 
p = 0.260).
Results were similar following 30 minutes of tcSCS in which 
8/10 subjects showed an increase in FSE (Figure 3D). Of the eight 
responders, four individuals had a clinically meaningful increase 
in FSE of 12° or greater, one individual had a moderate increase in 
FSE of 6–11°, and three individuals showed the least benefit with 
an increase in FSE of 1–5°. Analysis of the mean FSE did not show 
a statistically significant increase in FSE from baseline to immedi-
ately after tcSCS (Table 3; paired t-test, t = −2.249, p = 0.051) nor 
from baseline to 45 min after tcSCS treatment (Table 3; paired 
t-test, t = −1.946, p = 0.083). While the within-treatment effects 
of tcSCS were not statistically significant, it should be noted that 
4/10 subjects reported feeling a general reduction in spasticity 
and stiffness following tcSCS that persisted into the evening. No 
other intervention was reported to have these extended effects.
Stimulation over the motor cortex with tDCS for 20  min 
increased the FSE in 3/9 subjects, with two subjects showing a 
clinically meaningful increase in FSE and one subject showing 
a moderate increase in FSE (Figure  3E). When assessing the 
mean FSE, we found that there was no significant difference in 
FSE from baseline to either posttreatment time point (Table 3; 
immediate: paired-t-test, t = 0.099, p = 0.923; delayed: paired-t-
test, t = 0.488, p = 0.639).
In addition to the inter-individual variability in interven-
tion responses described in the preceding paragraphs, we also 
observed intra-individual variability in baseline FSE from session 
to session (Table 3; Figure 3). However, baseline FSE values were 
not different between any of the interventions, including the 
sham-control (one-way ANOVA, p = 0.795).
DiscUssiOn
The purpose of the current study was to compare the efficacy of 
four physical therapeutic/electroceutic interventions for prim-
ing the spinal reflex circuitry to reduce spasticity. Our results 
showed that physical therapeutic/electroceutic interventions can 
modulate the spinal reflex circuitry to reduce quadriceps spastic-
ity, as measured by an increase in the knee angle at which the 
quadriceps muscles first elicit a reflex muscle contraction (i.e., the 
FSE). When compared to the sham-control therapy, we observed 
a significant change in FSE (i.e., a decrease in spasticity) following 
stretching, CPM, and tcSCS at the immediate post- intervention 
assessment. tDCS showed no significant change in FSE as 
compared to sham-control. Furthermore, only CPM and tcSCS 
showed a persistent change in FSE 45-min post- intervention 
when compared to the sham-control. Secondary analyses of the 
within-treatment effects for each intervention showed that the 
sham-control intervention resulted in a significant decrease in 
FSE, indicating that spasticity worsens when an individual sits 
for an extended period of time. Taken together, these results sug-
gest that single physical therapeutic/ electroceutic interventions, 
including stretching, CPM and tcSCS, can be used to temporarily 
prime the spinal cord circuit and modulate reflex excitability for 
decreased spasticity.
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NIBS may be necessary to modulate spasticity. In the context of 
priming voluntary motor control, tDCS has been shown to be 
more efficacious when applied concurrently with task practice 
than when applied prior to task practice (37–40). Therefore, it is 
possible that tDCS may be a more efficacious priming stimulation 
for the modulation of involuntary motor activity when used in 
combination with another physical therapeutic/electroceutic 
intervention such as those that target afferent input.
Cortical topography is also a potential mediator of the 
efficacy of tDCS as a treatment for spasticity. To the best 
of our knowledge, anodal tDCS has been investigated as a 
physical therapeutic/electroceutic intervention for the manage-
ment only of upper extremity spasticity (28). In the current 
study, we targeted the leg representation of the motor cortex 
by applying stimulation over the vertex. However, the depth 
of current penetration with tDCS may make it more difficult 
to target the leg representation of the motor cortex than 
the arm and hand representation (41). The orientation and 
position of different limb representations in the motor cortex 
may potentially explain why we did not observe an effect of 
anodal tDCS on lower extremity spasticity when this type of 
priming stimulation has been shown to have an effect on upper 
extremity spasticity (28).
Interestingly, we observed a significant decrease in FSE (i.e., 
increase in spasticity) from baseline to 45 min post-intervention 
during the sham-control intervention when analyzing within-
treatment effects. This reduction in FSE while relaxing in a semi-
reclined position with the legs extended suggests that immobility 
increases stretch-induced quadriceps spasticity. In support of this 
idea, prolonged joint immobilization has been shown to induce 
spinal reflex hyperexcitability in non-injured individuals (14). 
Anecdotally, it is widely acknowledged in clinical circles that 
spasticity is worst in the morning after individuals have been in 
the same position for several hours overnight. Because the affer-
ent activation that occurs during movement plays an important 
role in the modulation of spinal reflex excitability (42), immobil-
ity likely increases spasticity due to a lack of afferent input. Our 
results suggest that individuals with spasticity should be encour-
aged to be as active as possible.
Given that this was an exploratory study, our conclusions are 
limited by the small number of participants, and additional studies 
are needed to corroborate our findings. It should be emphasized 
that each physical therapeutic/electroceutic intervention was 
applied only for a single session. While this precludes our ability 
to make direct comparisons with long-term treatments for spas-
ticity, our short-term results are promising in that we observed 
significant reductions in spasticity following single sessions of 
three physical therapeutic/electroceutic interventions, stretching, 
CPM and tcSCS. It should also be noted that while we applied 
tcSCS in a manner that would be more clinically accessible, i.e., 
without the verification of electrode placement using a posterior 
root motor reflex as conducted in previous studies utilizing tcSCS 
(9), it may have been possible to enhance the observed effects 
of tcSCS by verifying the placement. Furthermore, we did not 
assess segmental reflexes to determine the integrity of the lower 
motoneurons. However, the presence of lower extremity spastic-
ity indicates that the motoneurons of interest for this study were 
intact. We acknowledge that we measured a single manifestation 
of spasticity (i.e., involuntary, stretch-induced muscle activation) 
in one muscle group using a single outcome measure. For a more 
complete picture of the efficacy of these physical therapeutic/
electroceutic interventions in the treatment of spasticity, other 
manifestations of spasticity, beyond stretch-induced spasticity, 
should be evaluated.
It is important to reiterate the inter-individual differences 
observed with each physical therapeutic/electroceutic inter-
vention upon comparison to the sham-control. Immediately 
following treatment, the largest increase in FSE was observed 
following stretching for 4/10 subjects, following CPM for 4/10 
subjects, following tcSCS for 1/10 subjects, and following tDCS 
for 1/10 subjects. At the delayed assessment, CPM and tcSCS 
were each the most effective intervention for 4/10 subjects, while 
stretching and tDCS were each the most effective intervention 
for 1/10 subjects. When comparing differences in intervention 
efficacy among similar neurological levels of injury, CPM was 
the most effective intervention for 3/4 individuals with thoracic 
injury and stretching was the most effective intervention for 
the remaining one individual with thoracic injury at both the 
immediate and delayed post-intervention assessments. For the 
six individuals with a cervical injury, the most effective inter-
ventions at the immediate post-intervention assessment were 
stretching (3/6), CPM (1/6), tcSCS (1/6), and tDCS (1/6). At 
the delayed post-intervention assessment, tcSCS was the most 
effective intervention for 4/6 individuals with a cervical SCI. The 
remaining 2/6 individuals were divided so that CPM was the 
most effective intervention for one individual and tDCS was the 
most effective intervention for the other. These inter-individual 
differences in responsiveness to different treatments suggest that 
spasticity cannot be managed using a “one size fits all approach;” 
the same intervention is not likely to work for everyone. Because 
the efficacy of a given treatment is likely to be dependent on the 
clinical manifestation(s) of spasticity that an individual is expe-
riencing, future research should be dedicated to characterizing 
the mechanisms underlying the various clinical manifestations 
of spasticity.
cOnclUsiOn
In individuals with spasticity, aberrant involuntary motor activ-
ity can negatively impact quality of life. Because spasticity can 
cause stiffness and discomfort and interfere with an individual’s 
ability to position themselves, it has the potential to have a 
detrimental effect on a person’s ability to execute residual 
functional movements. While priming stimulation has previ-
ously been investigated as a means to facilitate voluntary motor 
control, in the current study we showed that it can also be used 
to modulate involuntary motor activity. We demonstrated that 
stretching, CPM and tcSCS can be utilized to prime the spinal 
reflex circuitry and reduce stretch-induced quadriceps spastic-
ity. Our results suggest that physical therapeutic/electroceutic 
interventions may be able to reduce spasticity to an extent that 
is comparable to that previously shown for pharmacological 
treatments. These approaches may therefore provide a means 
of spasticity management that is both cost-effective and free from 
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the deleterious side effects that accompany many antispasmodic 
medications. Future research should be dedicated to determin-
ing the most efficacious dosing strategies for these physical 
therapeutic/electroceutic interventions. Moreover, the efficacy 
of combined physical therapeutic/electroceutic interventions 
should be evaluated to determine whether applying two types 
of stimulation concurrently has a synergistic effect.
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